Paper656270
Chenodeoxycholic acid therapy for hypertriglyceridaemia in men.
Bateson MC and 3 others. Br J Clin Pharmacol, 1978. Cited by 66 papers, by iCite.
Cite this record
ConductScience Library. Chenodeoxycholic acid therapy for hypertriglyceridaemia in men. Papers, record 656270. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/656270
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Chenodeoxycholic Acid | Major topic |
| Hyperlipidemias | Major topic |
| Triglycerides | Major topic |
| Adult | |
| Aged | |
| Cholesterol | |
| Clofibrate | |
| Humans | |
| Liver Function Tests | |
| Male | |
| Middle Aged |
Source PubMed
References19
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 14262568 | A SYSTEM FOR PHENOTYPING HYPERLIPOPROTEINEMIA. | Circulation | 1965 | https://conductscience.org/library/papers/14262568 | PubMed |
| 2 | 5381845 | Clinical evaluation of a new hypolipidemic drug, CIBA 13,437-Su. | J Atheroscler Res | 1969 | https://conductscience.org/library/papers/5381845 | PubMed |
| 3 | 5539274 | Serum cholesterol, lipoproteins, and the risk of coronary heart disease. The Framingham study. | Ann Intern Med | 1971 | https://conductscience.org/library/papers/5539274 | PubMed |
| 4 | 4138590 | Triglyceride-lowering effect of chenodeoxycholic acid in patients with endogenous hypertriglyceridaemia. | Lancet | 1974 | https://conductscience.org/library/papers/4138590 | PubMed |
| 5 | 4152191 | Liver structure and function in cholelithiasis: effect of chenodeoxycholic acid. | Gut | 1974 | https://conductscience.org/library/papers/4152191 | PubMed |
| 6 | 4111826 | Ischaemic heart-disease in relation to fasting values of plasma triglycerides and cholesterol. Stockholm prospective study. | Lancet | 1972 | https://conductscience.org/library/papers/4111826 | PubMed |
| 7 | 4363888 | Treatment of hyperlipidemia. | N Engl J Med | 1974 | https://conductscience.org/library/papers/4363888 | PubMed |
| 8 | 4345943 | Serial lipid and lipoprotein responses to the American Heart Association fat-controlled diet. | Am J Med | 1971 | https://conductscience.org/library/papers/4345943 | PubMed |
| 9 | 47547 | Potential effect on coronary-heart-disease morbidity of lowering the blood-cholesterol. | Lancet | 1975 | https://conductscience.org/library/papers/47547 | PubMed |
| 10 | 4851965 | Experience with simplified scheme of treatment of hyperlipidaemia. | Br Med J | 1974 | https://conductscience.org/library/papers/4851965 | PubMed |
| 11 | 4817832 | Effect of bile acid feeding on cholesterol metabolism in gallstone patients. | Mayo Clin Proc | 1974 | https://conductscience.org/library/papers/4817832 | PubMed |
| 12 | 4741607 | Serum lipids in cholelithiasis: effect of chenodeoxycholic acid therapy. | Br Med J | 1973 | https://conductscience.org/library/papers/4741607 | PubMed |
| 13 | 4718952 | Hyperlipidemia in coronary heart disease. I. Lipid levels in 500 survivors of myocardial infarction. | J Clin Invest | 1973 | https://conductscience.org/library/papers/4718952 | PubMed |
| 14 | 4681896 | Increased prevalence of cholelithiasis in men ingesting a serum-cholesterol-lowering diet. | N Engl J Med | 1973 | https://conductscience.org/library/papers/4681896 | PubMed |
| 15 | 5041275 | Mechanisms of action of clofibrate on cholesterol metabolism in patients with hyperlipidemia. | J Lipid Res | 1972 | https://conductscience.org/library/papers/5041275 | PubMed |
| 16 | 4930042 | Classification of hyperlipidaemias and hyperlipoproteinaemias. | Bull World Health Organ | 1970 | https://conductscience.org/library/papers/4930042 | PubMed |
| 17 | 955328 | The medical treatment of cholesterol gallstones: experience with chenodeoxycholic acid. | Digestion | 1976 | https://conductscience.org/library/papers/955328 | PubMed |
| 18 | 1224909 | [The treatment of cholelithiasis by chenic acid. Present state of a prospective study (author's transl)]. | Acta Gastroenterol Belg | 1975 | https://conductscience.org/library/papers/1224909 | PubMed |
| 19 | 4818152 | Prevalence of hyperlipoproteinaemia in apparently healthy men. | Br Heart J | 1974 | https://conductscience.org/library/papers/4818152 | PubMed |
Cited by22
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 66 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42405097 | Amide-functionalized cholic acid hybrids: design, bioactivity, and computational analysis. | RSC Adv | 2026 | https://conductscience.org/library/papers/42405097 | PubMed |
| 36574136 | Lactiplantibacillus plantarum PGB02 Improved Serum Cholesterol Profile by Tweaking Genes Involved in Cholesterol Homeostasis in Male Swiss Albino Mice. | Appl Biochem Biotechnol | 2023 | https://conductscience.org/library/papers/36574136 | PubMed |
| 36263401 | Dietary supplementation of porcine bile acids improves laying performance, serum lipid metabolism and cecal microbiota in late-phase laying hens. | Anim Nutr | 2022 | https://conductscience.org/library/papers/36263401 | PubMed |
| 35495722 | Gut Microbiota Dysbiosis and Altered Bile Acid Catabolism Lead to Metabolic Disorder in Psoriasis Mice. | Front Microbiol | 2022 | https://conductscience.org/library/papers/35495722 | PubMed |
| 34950217 | Study on the Mechanism of Reducing Hepatotoxicity of Water-Grinding Realgar by Metabolomics, Morphology, and Chemical Analysis. | Evid Based Complement Alternat Med | 2021 | https://conductscience.org/library/papers/34950217 | PubMed |
| 30936623 | Human-specific dual regulations of FXR-activation for reduction of fatty liver using in vitro cell culture model. | J Clin Biochem Nutr | 2019 | https://conductscience.org/library/papers/30936623 | PubMed |
| 29409713 | Bilirubin in the Liver-Gut Signaling Axis. | Trends Endocrinol Metab | 2018 | https://conductscience.org/library/papers/29409713 | PubMed |
| 25500875 | Farnesoid X receptor: a master regulator of hepatic triglyceride and glucose homeostasis. | Acta Pharmacol Sin | 2015 | https://conductscience.org/library/papers/25500875 | PubMed |
| 25214402 | Vitamin D deficiency promotes nonalcoholic steatohepatitis through impaired enterohepatic circulation in animal model. | Am J Physiol Gastrointest Liver Physiol | 2014 | https://conductscience.org/library/papers/25214402 | PubMed |
| 23988487 | Bile acid receptors in non-alcoholic fatty liver disease. | Biochem Pharmacol | 2013 | https://conductscience.org/library/papers/23988487 | PubMed |
| 23447519 | Cholic acid for hepatic steatosis in patients with lipodystrophy: a randomized, controlled trial. | Eur J Endocrinol | 2013 | https://conductscience.org/library/papers/23447519 | PubMed |
| 22550135 | Bile acid receptors as targets for the treatment of dyslipidemia and cardiovascular disease. | J Lipid Res | 2012 | https://conductscience.org/library/papers/22550135 | PubMed |
| 21991404 | Bile Acid signaling in liver metabolism and diseases. | J Lipids | 2012 | https://conductscience.org/library/papers/21991404 | PubMed |
| 21431855 | Bile acid metabolism and the pathogenesis of type 2 diabetes. | Curr Diab Rep | 2011 | https://conductscience.org/library/papers/21431855 | PubMed |
| 21383957 | Deciphering the nuclear bile acid receptor FXR paradigm. | Nucl Recept Signal | 2010 | https://conductscience.org/library/papers/21383957 | PubMed |
| 20949026 | The bile acid sensor FXR protects against dyslipidemia and aortic plaques development induced by the HIV protease inhibitor ritonavir in mice. | PLoS One | 2010 | https://conductscience.org/library/papers/20949026 | PubMed |
| 20463294 | Pathogenesis of alcoholic liver disease: the role of nuclear receptors. | Exp Biol Med (Maywood) | 2010 | https://conductscience.org/library/papers/20463294 | PubMed |
| 20373033 | Effects of farnesoid X receptor on the expression of the fatty acid synthetase and hepatic lipase. | Mol Biol Rep | 2011 | https://conductscience.org/library/papers/20373033 | PubMed |
| 20041971 | FXR an emerging therapeutic target for the treatment of atherosclerosis. | J Cell Mol Med | 2010 | https://conductscience.org/library/papers/20041971 | PubMed |
| 15146238 | Bile acids lower triglyceride levels via a pathway involving FXR, SHP, and SREBP-1c. | J Clin Invest | 2004 | https://conductscience.org/library/papers/15146238 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/656270
GET https://conductscience.org/api/papers/v1/656270/cited_by?page=2